Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

RPR receives FDA clearance for new indication of enoxaparin

May 13, 1997

Serine protease inhibitors described by 3-D

May 12, 1997

BMS and Sanofi seek U.S. and European approval for clopidogrel

May 8, 1997

Genentech plans phase III studies of second-generation t-PA

May 7, 1997

Positive clinical results for desirudin in the prevention of thromboembolism

May 5, 1997

Vascular Therapeutics reports positive safety and efficacy profile for Vasoflux

April 28, 1997

Orally active antiplatelet agents disclosed by Mitsui Toatsu

April 22, 1997

Stable prostacyclins disclosed by Asahi Glass

April 21, 1997

Factor Xa inhibitors from Boehringer Mannheim

April 18, 1997

New fibrinogen antagonist from DuPont Merck

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.